RxDoctor Payments DataLook up a doctor →

Matthew Pabis, MD

Family Medicine · New York, NYNPI 1376981589

Payments from drug & device makers

$221,961in general payments, 2019–2025

Across 1,160 payments — averaging $191.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$135K
  • Axsome Therapeutics, Inc.$44K
  • Gilead$21K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
  • AbbVie$3K
  • Viiv Healthcare Company$2K
  • plus $11K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.222$135,484
Axsome Therapeutics, Inc.57$44,278
Gilead219$21,409
Otsuka Pharmaceutical Development & Commercialization, Inc.6$5,745
AbbVie(2 entities)108$2,501
Viiv Healthcare Company73$1,953
Lundbeck LLC77$1,400
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC70$1,080
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)34$854
Takeda Pharmaceuticals U.S.A., Inc.43$821
Johnson & Johnson25$687
Otsuka America Pharmaceutical, Inc.26$580
Amgen(2 entities)20$541
GSK25$539
Bristol Myers Squibb12$469
Corium, LLC9$298
Lilly USA, LLC15$272
Medtronic4$258
Teva Pharmaceuticals USA, Inc.11$258
Orexo US, Inc.13$240
AstraZeneca12$237
Vanda Pharmaceuticals Inc.11$233
Janssen Scientific Affairs, LLC1$200
Paratek Pharmaceuticals, Inc.10$170
Cardiovascular Systems Inc.2$154
Exact Sciences5$135
Smith+Nephew1$128
Indivior Inc.5$118
Kowa Pharmaceuticals America, Inc.6$99
Almatica Pharma LLC4$79
E.r. Squibb & Sons, L.L.C.2$70
Avanir Pharmaceuticals, Inc.4$63
Sunovion Pharmaceuticals Inc.5$63
MDD US Operations, LLC1$54
Supernus Pharmaceuticals, Inc.2$52
Antares Pharma, Inc.3$49
Pfizer2$45
Collegium Pharmaceutical, Inc.2$43
Bausch Health US, LLC2$41
EMD Serono, Inc.1$36
Neuronetics, Inc.1$29
Phathom Pharmaceuticals, Inc.1$29
Neurocrine Biosciences, Inc.1$29
Hologic Sales And Service, LLC1$26
Biohaven Pharmaceutical Holding Company Ltd.1$25
Idorsia Pharmaceuticals US Inc1$21
Genentech USA, Inc.1$20
Redhill Biopharma Inc.1$19
Braeburn Inc.1$15
Biohaven Pharmaceuticals, Inc.1$14

How this compares

$221,961 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Medicare billing

Part B allowed, 2024
$22,693
Medicare patients
59
Services billed
249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →